Partnership Opportunities
The 5th Fc-Mediated Function Summit offers an unparalleled platform to connect directly with 50+ senior leaders, pioneering Fc therapeutics and driving innovation in antibody therapeutics. Position your company at the forefront of this rapidly evolving and highly innovative field and forge strategic partnerships that will accelerate your growth and impact. Connect with a highly targeted audience and experts dedicated to the intricacies of Fc biology and its therapeutic applications for drugs targeting oncology and autoimmune disease.
This summit creates the ideal environment to cultivate meaningful collaborations and explore synergistic opportunities with companies. Join us to network with influential voices from leading biopharma companies including Seismic Therapeutics, Tacalyx Therapeutics, and Genentech, and unlock the potential for transformative partnerships that will shape the future of antibody-based medicines.
Current Partners:
What is the Industry Looking for?
Immunoassay Support: Assistance with the development, optimization, and execution of assays that detect and quantify specific molecules to understand biological processes and therapeutic efficacy.
Antibody Binding Services: Specialized services that analyze and characterize the interaction between antibodies and their target antigens, are crucial for understanding therapeutic mechanisms and selecting lead candidates.
Transgenic Mice: Genetically modified mice expressing specific human genes or lacking certain mouse genes, serving as preclinical models to study human disease and evaluate the efficacy and safety of novel therapeutics.
Preclinical CROs: Contract research organizations that provide comprehensive services for preclinical drug development, including study design, in vivo and in vitro testing, and data analysis to assess the safety and efficacy of therapeutic candidates before human trials.
Why Partner?
Gain Unparalleled Brand Visibility: Reach a highly focused audience of 50+ senior leaders from top biopharma companies actively involved in Fc-mediated therapeutic drug development
Showcase Your Innovative Solutions: Position your company as a thought leader in the cutting-edge field of Fc-mediated therapeutics and highlight your offerings to a summit dedicated to key decision-makers
Gain Valuable Market Insights: Stay ahead of the curve by gaining exclusive access to the latest scientific advancements, emerging technologies, and critical trends shaping the future of Fc-mediated therapies from extending antibody half-life and engineering Fc-regions for better affinity
Forge Strategic Partnerships: Engage in meaningful discussions and identify synergistic opportunities with leading organizations, including UCB and Novartis to accelerate innovation and expand your reach within the antibody therapeutics market
Want to get involved?
Speak with the Partnerships Director today to learn more about the bespoke opportunities available.
Who Will You Meet?
